← Back to headlines
Adaptive Biotechnologies Faces Scrutiny After COO Sells Shares
Questions arise regarding Adaptive Biotechnologies' stock performance following the sale of 57,000 shares by its President and COO.
18 Apr, 14:57 — 18 Apr, 14:57
Sources
Showing 1 of 1 sources
